Elwir Saleh, Lake John
Dr Elwir is a gastroenterology and hepatology fellow and Dr Lake is a professor of medicine in the Division of Gastroenterology, Hepatology, and Nutrition at the University of Minnesota in Minneapolis, Minnesota. Dr Lake is also the executive medical director of the solid organ transplant program at the University of Minnesota.
Gastroenterol Hepatol (N Y). 2016 Mar;12(3):166-70.
The liver transplant allocation system is currently based upon the Model for End-Stage Liver Disease (MELD) score and allocates organs preferentially to patients with the highest scores (ie, the sickest patients) within a defined geographic unit. In addition, certain patient populations, such as patients with hepatocellular carcinoma and portopulmonary hypertension, receive MELD exception points to account for their increased waitlist mortality, which is not reflected by their MELD score. Significant geographic variation in the access to liver transplantation exists throughout the United States. Both the Organ Procurement and Transplant Network Board of Directors and the Health Resources and Services Administration have determined these geographic disparities to be unacceptable. The liver transplant community has worked to develop methods to reduce these geographic disparities and to reexamine how MELD exception points are granted to certain patient populations. As a result, numerous policy changes have been adopted throughout the years that have broadened the sharing of organs through wider geographic sharing. Despite all of these changes, variation in access to liver transplantation continues to exist, and, thus, the liver transplant community continues to examine new ways to address geographic disparities. This paper reviews several of the key changes to the liver allocation system that have occurred since the implementation of MELD allocation in 2002 and provides an overview of potential changes to the system.
肝移植分配系统目前基于终末期肝病模型(MELD)评分,在特定地理区域内,优先将器官分配给评分最高的患者(即病情最严重的患者)。此外,某些患者群体,如肝细胞癌患者和门肺高压患者,会获得MELD例外积分,以考虑其在等待名单上更高的死亡风险,而这在其MELD评分中并未体现。在美国,肝移植的可及性存在显著的地理差异。器官获取与移植网络董事会和卫生资源与服务管理局均认定这些地理差异是不可接受的。肝移植领域一直在努力制定方法来减少这些地理差异,并重新审视如何向某些患者群体授予MELD例外积分。因此,多年来已实施了多项政策变革,通过扩大地理共享范围来拓宽器官分配。尽管有所有这些变化,肝移植可及性的差异仍然存在,因此,肝移植领域继续探索解决地理差异的新方法。本文回顾了自2002年实施MELD分配以来肝分配系统发生的一些关键变化,并概述了该系统可能的变化。